المؤلفون: Wiesen MHJ; Therapeutic Drug Monitoring, Pharmacology at the Laboratory Diagnostics Centre, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Department of Clinical Chemistry, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Stemler J; Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Fietz C; Therapeutic Drug Monitoring, Pharmacology at the Laboratory Diagnostics Centre, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Joisten C; Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Cornely OA; Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Cologne, Germany., Verougstraete N; Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium., Streichert T; Therapeutic Drug Monitoring, Pharmacology at the Laboratory Diagnostics Centre, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Department of Clinical Chemistry, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Müller C; Therapeutic Drug Monitoring, Pharmacology at the Laboratory Diagnostics Centre, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

المصدر: European journal of haematology [Eur J Haematol] 2024 Jun; Vol. 112 (6), pp. 879-888. Date of Electronic Publication: 2024 Jan 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Staurosporine*/*analogs & derivatives, Staurosporine*/therapeutic use , Staurosporine*/administration & dosage , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/blood , Tandem Mass Spectrometry*, Humans ; Male ; Female ; Middle Aged ; Aged ; Chromatography, Liquid/methods ; Adult ; Drug Monitoring/methods ; fms-Like Tyrosine Kinase 3/antagonists & inhibitors ; fms-Like Tyrosine Kinase 3/blood ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/blood ; Protein Kinase Inhibitors/pharmacokinetics ; Reproducibility of Results ; Cohort Studies

المؤلفون: Yang Q; State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Gao W; State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Li X; State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Li X; State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Zhou X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, 100142, China., Li W; State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Zhou C; Biobank, Cancer Research Center, Shandong Cancer Hospital, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, China., Luo A; State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China., Liu Z; State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

المصدر: Advanced healthcare materials [Adv Healthc Mater] 2024 Jun; Vol. 13 (16), pp. e2400381. Date of Electronic Publication: 2024 Mar 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101581613 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2192-2659 (Electronic) Linking ISSN: 21922640 NLM ISO Abbreviation: Adv Healthc Mater Subsets: MEDLINE

مواضيع طبية MeSH: ATP Binding Cassette Transporter 1*/metabolism , ATP Binding Cassette Transporter 1*/genetics , Staurosporine*/pharmacology , Staurosporine*/analogs & derivatives , Extracellular Vesicles*/metabolism , Radiation Tolerance*/drug effects, Humans ; Animals ; Cell Line, Tumor ; Mice ; Cell Proliferation/drug effects ; Neoplastic Stem Cells/drug effects ; Neoplastic Stem Cells/metabolism ; Esophageal Neoplasms/drug therapy ; Esophageal Neoplasms/pathology ; Esophageal Neoplasms/metabolism ; Esophageal Neoplasms/therapy ; Mice, Nude ; Esophageal Squamous Cell Carcinoma/drug therapy ; Esophageal Squamous Cell Carcinoma/pathology ; Esophageal Squamous Cell Carcinoma/metabolism ; Mice, Inbred BALB C

المؤلفون: Tinajero J; Department of Pharmacy, City of Hope Medical Center, Duarte, CA, USA., Ngo D; Department of Pharmacy, City of Hope Medical Center, Duarte, CA, USA., Zhang J; Division of Biostatistics, City of Hope Medical Center, Duarte, CA, USA., Tsai NC; Division of Biostatistics, City of Hope Medical Center, Duarte, CA, USA., Aribi A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Agrawal V; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Arslan S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Amanam I; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Pourhassan H; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Sandhu K; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Al-Malki M; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Pullarkat V; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Becker P; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Nakamura R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Stein A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Marcucci G; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Artz A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Koller P; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA., Salhotra A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2024 Jul; Vol. 65 (7), pp. 1020-1023. Date of Electronic Publication: 2024 Apr 18.

نوع المنشور: Letter; Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/therapy , Leukemia, Myeloid, Acute*/diagnosis , Leukemia, Myeloid, Acute*/drug therapy , Mutation* , Remission Induction* , Staurosporine*/analogs & derivatives , Staurosporine*/therapeutic use, Aged ; Female ; Humans ; Male ; Middle Aged ; fms-Like Tyrosine Kinase 3/genetics ; Transplantation, Homologous ; Treatment Outcome

المؤلفون: Röllig C; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany., Schliemann C; Department of Medicine A, University Hospital Münster, Münster, Germany., Ruhnke L; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany., Fransecky L; Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Heydrich BN; Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Hanoun M; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Noppeney R; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Schäfer-Eckart K; Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany., Wendelin K; Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany., Mikesch JH; Department of Medicine A, University Hospital Münster, Münster, Germany., Middeke JM; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany., Reimann M; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany., Fiebig F; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany., Zukunft S; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany., Wermke M; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany., Serve H; Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany., Platzbecker U; Department of Internal Medicine I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany., Müller-Tidow C; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany., Baldus CD; Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Bornhäuser M; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; National Center for Tumor Diseases Dresden, Dresden, Germany.

المصدر: British journal of haematology [Br J Haematol] 2024 Jun; Vol. 204 (6), pp. 2254-2258. Date of Electronic Publication: 2024 Apr 09.

نوع المنشور: Journal Article; Clinical Trial, Phase I

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Staurosporine*/analogs & derivatives , Staurosporine*/administration & dosage , Staurosporine*/therapeutic use , Staurosporine*/adverse effects , Gemtuzumab*/administration & dosage , Gemtuzumab*/therapeutic use , Leukemia, Myeloid, Acute*/drug therapy , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage, Humans ; Male ; Middle Aged ; Female ; Aged ; Adult ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antibodies, Monoclonal, Humanized/adverse effects ; Induction Chemotherapy ; fms-Like Tyrosine Kinase 3/genetics ; Aminoglycosides/administration & dosage ; Aminoglycosides/therapeutic use

المؤلفون: Tedjaseputra A; Monash Haematology, Clayton, Vic, Australia., Roy S; Monash Haematology, Clayton, Vic, Australia., Htun K; Monash Haematology, Clayton, Vic, Australia., Oh D; Monash Haematology, Clayton, Vic, Australia., McQuilten Z; Monash Haematology, Clayton, Vic, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia., Yeh P; Monash Haematology, Clayton, Vic, Australia; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Vic, Australia., Bennett A; Monash Haematology, Clayton, Vic, Australia; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Vic, Australia., Low MSY; Monash Haematology, Clayton, Vic, Australia; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Vic, Australia., Chunilal S; Monash Haematology, Clayton, Vic, Australia; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Vic, Australia., Wood EM; Monash Haematology, Clayton, Vic, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia., Shortt J; Monash Haematology, Clayton, Vic, Australia; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Vic, Australia. Electronic address: jake.shortt@monash.edu.

المصدر: Pathology [Pathology] 2024 Jun; Vol. 56 (4), pp. 548-555. Date of Electronic Publication: 2024 Mar 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3931 (Electronic) Linking ISSN: 00313025 NLM ISO Abbreviation: Pathology Subsets: MEDLINE

مواضيع طبية MeSH: Staurosporine*/analogs & derivatives , Staurosporine*/therapeutic use , fms-Like Tyrosine Kinase 3*/genetics , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/pathology , Neoplasm, Residual* , Bone Marrow*/pathology, Humans ; Male ; Female ; Middle Aged ; Adult ; Retrospective Studies ; Aged ; Mutation ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Remission Induction

المؤلفون: Sechaud R; Novartis Pharma AG, 4002, Basel, Switzerland. romain.sechaud@novartis.com., Gu H; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Rahmanzadeh G; Novartis Pharma AG, 4002, Basel, Switzerland., Taylor A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Chiparus O; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Sharma GK; Novartis Healthcare Pvt. Ltd., Hyderabad, Telangana, 50081, India., Breitschaft A; Parexel International GmbH, 14059, Berlin, Germany., Menssen HD; Novartis Pharma AG, 4002, Basel, Switzerland.

المصدر: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 May; Vol. 93 (5), pp. 439-453. Date of Electronic Publication: 2024 Jan 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Bupropion*/pharmacokinetics , Bupropion*/administration & dosage , Cytochrome P-450 CYP2B6*/metabolism , Cytochrome P-450 CYP2B6*/genetics , Cytochrome P-450 CYP2C8*/metabolism , Cytochrome P-450 CYP3A*/metabolism , Drug Interactions* , Midazolam*/pharmacokinetics , Midazolam*/administration & dosage , Staurosporine*/analogs & derivatives , Staurosporine*/pharmacology , Staurosporine*/pharmacokinetics , Staurosporine*/administration & dosage, Humans ; Area Under Curve ; Contraceptives, Oral/administration & dosage ; Contraceptives, Oral/pharmacology ; Contraceptives, Oral/pharmacokinetics ; Drug Combinations ; Ethinyl Estradiol/pharmacokinetics ; Ethinyl Estradiol/administration & dosage ; Ethinyl Estradiol/pharmacology ; Healthy Volunteers ; Levonorgestrel/pharmacokinetics ; Levonorgestrel/administration & dosage ; Levonorgestrel/pharmacology ; Pioglitazone/pharmacology ; Pioglitazone/administration & dosage ; Pioglitazone/pharmacokinetics ; Male ; Female ; Adolescent ; Young Adult ; Adult ; Middle Aged

المؤلفون: Wang LY; Department of Hematology, Fujian Medical University Union Hospital, Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fuzhou 350001, Fujian Province, China., Jiang PF; Fujian Medical University, Fuzhou 350001, Fujian Province, China., Li JZ; Fujian Medical University, Fuzhou 350001, Fujian Province, China., Chen YX; Department of Hematology, Fujian Medical University Union Hospital, Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fuzhou 350001, Fujian Province, China., Hu JD; Department of Hematology, Fujian Medical University Union Hospital, Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fuzhou 350001, Fujian Province, China.; Fujian Medical University, Fuzhou 350001, Fujian Province, China.; The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian Province, China.; Institute of Precision Medicine, Fujian Medical University, Fuzhou 350001, Fujian Province, China. E-mail: drjiandahu@163.com.

المصدر: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2024 Apr; Vol. 32 (2), pp. 395-401.

نوع المنشور: English Abstract; Journal Article

بيانات الدورية: Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN: 1009-2137 (Print) Linking ISSN: 10092137 NLM ISO Abbreviation: Zhongguo Shi Yan Xue Ye Xue Za Zhi Subsets: MEDLINE

مواضيع طبية MeSH: MicroRNAs*/genetics , Leukemia, Myeloid, Acute*/genetics , fms-Like Tyrosine Kinase 3*/genetics , Phenylurea Compounds*, Staurosporine/*analogs & derivatives, Humans ; Cell Line, Tumor ; Signal Transduction ; Doxorubicin/pharmacology ; Drug Resistance, Neoplasm ; Benzothiazoles/pharmacology ; Staurosporine/pharmacology ; TOR Serine-Threonine Kinases/metabolism ; Wnt Signaling Pathway

المؤلفون: Kennedy A; Tufts Medical Center, Department of Internal Medicine, Boston, MA, USA.; University of Massachusetts Chan Medical School, Worcester, MA, USA., Patel S; Division of Hematology and Oncology, Department of Internal Medicine, UMass Memorial Health Care, Worcester, MA, USA., Ramanathan M; Division of Hematology and Oncology, Department of Internal Medicine, UMass Memorial Health Care, Worcester, MA, USA., Gerber J; Division of Hematology and Oncology, Department of Internal Medicine, UMass Memorial Health Care, Worcester, MA, USA., Cerny J; Division of Hematology and Oncology, Department of Internal Medicine, UMass Memorial Health Care, Worcester, MA, USA. jan.cerny@umassmemorial.org.

المصدر: Annals of hematology [Ann Hematol] 2024 Mar; Vol. 103 (3), pp. 1031-1033. Date of Electronic Publication: 2024 Jan 09.

نوع المنشور: Letter

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Protein Kinase Inhibitors* , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics, Staurosporine/*analogs & derivatives, Humans ; Staurosporine/therapeutic use ; fms-Like Tyrosine Kinase 3/genetics ; Mutation

المؤلفون: Alati C; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Pitea M; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Mico MC; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Marafioti V; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Greve B; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Pratico G; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Loteta B; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Cogliandro F; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Porto G; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Policastro G; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Utano G; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Sgarlata A; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Imbalzano L; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Delfino IM; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Montechiarello E; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Germano J; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Filippelli G; Oncology Department, Hospital of Paola (Cosenza), Cosenza, Italy., Martino M; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy.

المصدر: Expert review of hematology [Expert Rev Hematol] 2024 Aug; Vol. 17 (8), pp. 515-525. Date of Electronic Publication: 2024 Jul 21.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485942 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4094 (Electronic) Linking ISSN: 17474094 NLM ISO Abbreviation: Expert Rev Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/therapy , Leukemia, Myeloid, Acute*/drug therapy , Maintenance Chemotherapy*, Humans ; fms-Like Tyrosine Kinase 3/antagonists & inhibitors ; fms-Like Tyrosine Kinase 3/metabolism ; Hematopoietic Stem Cell Transplantation ; Staurosporine/analogs & derivatives ; Staurosporine/therapeutic use ; Protein Kinase Inhibitors/therapeutic use ; Antineoplastic Agents/therapeutic use ; Sorafenib/therapeutic use ; Phenylurea Compounds/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Aniline Compounds ; Pyrazines ; Benzothiazoles

المؤلفون: Yang L; State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, PR China., Guo CW; State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, PR China., Luo QM; State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, PR China., Guo ZF; State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, PR China., Chen L; State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, PR China., Ishihama Y; Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, 606-8501, Japan., Li P; State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, PR China. Electronic address: liping2004@126.com., Yang H; State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, PR China. Electronic address: yanghuacpu@126.com., Gao W; State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, PR China; Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, 606-8501, Japan. Electronic address: gw_cpu@126.com.

المصدر: Analytica chimica acta [Anal Chim Acta] 2024 Jul 11; Vol. 1312, pp. 342755. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0370534 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4324 (Electronic) Linking ISSN: 00032670 NLM ISO Abbreviation: Anal Chim Acta Subsets: MEDLINE

مواضيع طبية MeSH: Proteolysis*, Humans ; Mass Spectrometry/methods ; Lactams, Macrocyclic/pharmacology ; Lactams, Macrocyclic/chemistry ; Benzoquinones/chemistry ; Benzoquinones/pharmacology ; Temperature ; Pentacyclic Triterpenes/chemistry ; Cyclosporine/pharmacology ; Cyclosporine/chemistry ; Cyclosporine/metabolism ; Staurosporine/pharmacology ; Staurosporine/metabolism ; Ligands ; Drug Discovery ; Binding Sites